Literature DB >> 11332306

First-line drugs for hypertension.

J D Spence.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11332306      PMCID: PMC80672     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

Review 1.  Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 2: Beta-blockers.

Authors:  J M Wright
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

2.  Persistence with treatment for hypertension in actual practice.

Authors:  J J Caro; M Salas; J L Speckman; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

3.  Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data.

Authors:  J J Caro; J L Speckman; M Salas; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

4.  Awareness, treatment, and control of hypertension in Canada.

Authors:  M R Joffres; P Ghadirian; J G Fodor; A Petrasovits; A Chockalingam; P Hamet
Journal:  Am J Hypertens       Date:  1997-10       Impact factor: 2.689

Review 5.  Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 3: Angiotensin-converting-enzyme inhibitors.

Authors:  J M Wright
Journal:  CMAJ       Date:  2000-08-08       Impact factor: 8.262

6.  Continuation of initial antihypertensive medication after 1 year of therapy.

Authors:  B S Bloom
Journal:  Clin Ther       Date:  1998 Jul-Aug       Impact factor: 3.393

Review 7.  Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 1: Thiazide diuretics.

Authors:  J M Wright
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

8.  The direct costs to the NHS of discontinuing and switching prescriptions for hypertension.

Authors:  D Hughes; A McGuire
Journal:  J Hum Hypertens       Date:  1998-08       Impact factor: 3.012

  8 in total
  1 in total

1.  The value of industry-sponsored studies of initial antihypertensive therapies.

Authors:  J J Caro; K Payne
Journal:  CMAJ       Date:  2001-06-26       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.